Unraveling the discrepancies between REDUCE-IT and STRENGTH trials with omega-3 fatty acids: new analytical approaches

Unraveling the discrepancies between REDUCE-IT and STRENGTH trials with omega-3 fatty acids: new analytical approaches

Two large-scale, randomized, double-blind, placebo-controlled trials—REDUCE-IT and STRENGTH—have garnered significant attention in cardiovascular medicine. Both trials aimed to evaluate the effects of prolonged administration of nutritional lipids, specifically omega-3 fatty acids, on major adverse...

Full description

Bibliographic Details
Main Authors: Weiguo Zhang, Dan Gan, Shaofeng Huo, Peng Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Nutrition
Subjects:
major adverse cardiovascular events (MACEs)
residual cardiovascular risk (RCR)
eicosapentaenoic acid (EPA)
docosahexaenoic acid (DHA)
resting heart rate (RHR)
heart rate variability (HRV)
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2024.1490953/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2024.1490953/full

Similar Items